🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Nutrition for People with Diabetes and Kidney Disease buff.ly/nt6hKja According to the Centers for Disease Control, as many as 1 in 3 people with diab

New European Atherosclerosis Society consensus statement ✍️Clinical staging to guide management of metabolic disorders/sequelae ✍️A framework to support earlier identification/improved care of people at risk of cardiometabolic diseases. lnkd.in/dAbJJ6BH #EASCongress2025

Do I have a second? Reducing the burden of chronic kidney disease in the world - The Lancet thelancet.com/journals/lance…

Available head-to-head RCTs comparing non-steroidal MRA finerenone versus steroidal MRA spironolactone #HeartFailure2025

Prevalence and severity of chronic kidney disease in a population with... sciencedirect.com/science/articl… CKD remains common and serious in type 1 diabetes: 1 of 3 persons and kidney failure in one-fifth of them. Time to do better!

CKD remains common and serious in type 1 diabetes: 1 of 3 persons and kidney failure in one-fifth of them. Time to do better! Open access via The Lancet journals. ars.els-cdn.com/content/image/…

The VISIONARY trial of sibeprenlimab in IgA nephropathy is the first P3 trial of an APRIL inhibitor. Results being presented in as a late-breaker at ERA - European Renal Association next Friday by Vlado Perkovic I spoke with HCPLive about APRIL inhibitors and VISIONARY more specifically:

It was a privilege to offer opening remarks this morning as we kicked off Research Day 2025 at our @UTMBHealth Galveston Campus. Hosted by Interim Senior Vice President & Dean, John Sealy School of Medicine, and Chief Research Officer, Dr. Antonio Bianco, and the Council of Vice

Research Day at UTMB Health's Galveston Campus celebrated the work of students, faculty, and researchers. Hosted by Dr. Bianco and the Council of Vice Chairs for Research, it featured keynote speaker Dr. Tuttle (Katherine Tuttle), a leader in nephrology and translational science.

Good morning from Vienna 🇦🇹 ☀️! If you’re here at #ERA2025, come join us for lunch & talks on #IgAN in Hall C at 1pm! ⁦Dana Rizk⁩ ⁦R Lafayette⁩

For #ERA25 attendees check out the WKD editorial on minding the gap academic.oup.com/ajh/article/37… from Valerie Luyckx Katherine Tuttle @vasuragh Fiona Loud 💙 and colleagues #OpenAccess

Optimizing the timing and sequencing of guideline-directed medical therapy for T2D and CKD ca. 2024 from Brendon Neuen Katherine Tuttle george bakris George Bakris Muthu Vaduganathan #ERA25 🇦🇹 #Nephpearls #Cardiorenal 👉 pubmed.ncbi.nlm.nih.gov/40179265/

About last night—an amazing Vienna farewell with some of the biggest “game changers” in Nephrology!!#ERA2025 ⁦Katherine Tuttle⁩ ⁦Vlado Perkovic⁩ ⁦Matthias Kretzler⁩ ⁦Hiddo Heerspink⁩ ⁦Jula Inrig⁩ ⁦International Society of Glomerular Disease⁩

Dietary Protein Intake Recommendations for Patients with Non-Dialysis Dependent CKD: What Should Healthcare Providers Do? Read this article in #ASNCJASN "Kidney Cross-Talk" series to learn more. kidney.pub/CJASN0772

Systemic Inflammation and the Risks of Adverse Kidney Outcomes in Adults With Atherosclerotic Cardiovascular Disease bit.ly/Mazhar25OI #OpenAccess #VisualAbstract Edouard L. Fu Vlado Perkovic Katherine Tuttle Juan Jesus Carrero

Our very own, Dr. Joshua J. Neumiller, delivering his ADA Presidential address. We are so very proud of him. Bravo!👏

Huge privilege - eager, insightful, innovative sharing of experience/strategies to reduce scourge of PrAKI Pregnancy associated acute kidney injury ⁦⁩ ⁦⁦Dr. Divya Bajpai 🇮🇳⁩ ⁦kate bramham⁩ ⁦Rolando Claure, MD, FASN, FISN 🇧🇴⁩ ⁦pADQI⁩ ⁦Robert Kalyesubula,MD, FISN(USA), PhD-FRCP(London)⁩ ⁦Rasha shemies⁩

From #ADASciSessions: Compared with placebo, #tirzepatide was associated with a slower decline in #eGFR among patients with #prediabetes and overweight or #obesity. American Diabetes Association - DiabetesPro Diabetes, a research journal of the ADA 🧪 Katherine Tuttle Petter Bjornstad, M.D. endocrinologyadvisor.com/reports/tirzep…

Systemic Inflammation and the Risks of Adverse Kidney Outcomes in Adults With Atherosclerotic Cardiovascular Disease bit.ly/Mazhar25OI #OpenAccess #VisualAbstract Edouard L. Fu Vlado Perkovic Katherine Tuttle Juan Jesus Carrero

New episode this week! We discuss pragmatic trial infrastructure in Denmark, implementation science in nephrology and how new approaches to recruitment can improve access, equity and representation in trials #kidneycompass